Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative ...

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with ...

For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and toxicity.

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...

Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia Drivers of variation in the cost ...

Intensity-modulated proton therapy (IMPT) improves overall survival (OS) and reduces high-grade toxicity compared with intensity-modulated radiation ...

Head and neck cancer (HNC) encompasses a group of neoplasms that affect the paranasal sinuses, nasal and oral cavities, pharynx, and larynx [1]. Although HNC accounts for only 4% of all cancer cases, ...

The treatment of head and neck cancer by radiotherapy has undergone significant evolution over recent years. Modern protocols combine highly conformal intensity‐modulated radiotherapy (IMRT) with ...

The proportion of second cancers related to radiotherapy treatment for the first cancer in adulthood is small (about 8%), concludes an Article published Online First in The Lancet Oncology. The ...